DHR RSI
Danaher Corporation
Danaher is a global science and technology innovator that designs and manufactures products for life sciences, diagnostics, and biotechnology to solve complex healthcare challenges.
Historical oversold levels
Track when DHR has reached oversold conditions (RSI below 30) historically. These levels often present potential buying opportunities.
What is DHR?
Danaher started in 1969 as a real estate trust, but everything changed when the Rales brothers took over in the 80s. They turned it into a lean manufacturing giant named after a Montana fishing creek. Over decades, they evolved from making tools and industrial gear into an elite life sciences and diagnostics powerhouse. Their secret sauce is the Danaher Business System, a culture of continuous improvement that they apply to every company they buy.
Today, the business is built on three main pillars: Biotechnology, Life Sciences, and Diagnostics. Through brands like Cytiva and Pall, they provide the essential picks and shovels for drug manufacturing, especially for complex biologics and cell therapies. On the diagnostic side, companies like Cepheid and Beckman Coulter are leaders in clinical testing and rapid molecular diagnostics. They effectively own the infrastructure of modern medicine.
Historically, Danaher is known for its aggressive and successful M&A strategy. The 2020 acquisition of GE’s biopharma business for 21 billion dollars was a game-changer, cementing their dominance in bioprocessing. They have also been busy trimming the fat, spinning off industrial units like Fortive and Veralto to become a pure-play healthcare innovator. Financially, they are a cash flow machine with high recurring revenue, which gives them the dry powder to keep acquiring high-growth assets.
Looking toward 2026, Danaher is positioning itself for a major growth cycle. While the post-pandemic bioprocessing cliff slowed things down recently, the inventory destocking phase is ending. By 2026, expect Danaher to capitalize on the next wave of genomic medicine and mRNA-based therapies. They are doubling down on digital pathology and AI-driven diagnostics to speed up clinical workflows. The strategy is clear: stay lean, buy the best niche players, and remain the indispensable partner for every major pharmaceutical company and hospital system in the world.
What is RSI?
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.
For DHR, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, Danaher Corporation is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.
Understanding DHR RSI Signals
- Oversold (RSI below 30): When DHR RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
- Overbought (RSI above 70): An RSI above 70 indicates DHR may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
- Divergences: When DHR price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.
Daily vs Weekly RSI for DHR
This page displays both daily and weekly RSI for DHR. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.
By analyzing both timeframes together, you can better understand Danaher Corporation's momentum at multiple levels and make more informed trading decisions.
Historical RSI Oversold Analysis
Above, we track historical instances when DHR RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how Danaher Corporation has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.
Assets with similar RSI
Assets currently trading with RSI levels close to DHR